Repurposed Edaravone, Metformin, and Perampanel as a Potential Treatment for Hypoxia–Ischemia Encephalopathy: An In Vitro Study
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Repurposed Edaravone, Metformin, and Perampanel as a Potential Treatment for Hypoxia–Ischemia Encephalopathy: An In Vitro Study
Authors
Keywords
-
Journal
Biomedicines
Volume 10, Issue 12, Pages 3043
Publisher
MDPI AG
Online
2022-11-28
DOI
10.3390/biomedicines10123043
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of the Edaravone, a Drug Approved for the Treatment of Amyotrophic Lateral Sclerosis, on Mitochondrial Function and Neuroprotection
- (2022) Sun Joo Cha et al. Antioxidants
- Perampanel, an AMPAR antagonist, alleviates experimental intracerebral hemorrhage‑induced brain injury via necroptosis and neuroinflammation
- (2021) Lixiang Yang et al. Molecular Medicine Reports
- Current Therapies for Neonatal Hypoxic–Ischaemic and Infection-Sensitised Hypoxic–Ischaemic Brain Damage
- (2021) Konstantina Tetorou et al. Frontiers in Synaptic Neuroscience
- Behavioral and brain morphological analysis of non-inflammatory and inflammatory rat models of preterm brain injury
- (2021) Ruben Rocha et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- Metformin Inhibits Propofol-Induced Apoptosis of Mouse Hippocampal Neurons HT-22 Through Downregulating Cav-1
- (2020) Jianyun Ge et al. Drug Design Development and Therapy
- Optimization of cell viability assays to improve replicability and reproducibility of cancer drug sensitivity screens
- (2020) Peter Larsson et al. Scientific Reports
- Edaravone Improves Intermittent Hypoxia-Induced Cognitive Impairment and Hippocampal Damage in Rats
- (2020) Jizu Ling et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Drug Repurposing: Promises of Edaravone Target Drug in Traumatic Brain Injury
- (2020) Zaynab Shakkour et al. CURRENT MEDICINAL CHEMISTRY
- Protective effects of combined treatment with mild hypothermia and edaravone against cerebral ischemia/reperfusion injury via oxidative stress and Nrf2 pathway regulation
- (2020) Hang Yu et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Low doses of Perampanel protect striatal and hippocampal neurons against in vitro ischemia by reversing the ischemia-induced alteration of AMPA receptor subunit composition
- (2020) Petra Mazzocchetti et al. NEUROBIOLOGY OF DISEASE
- Preterm Brain Injury, Antenatal Triggers, and Therapeutics: Timing Is Key
- (2020) Daan R.M.G. Ophelders et al. Cells
- The impact of perampanel and targeting AMPA transmission on anti-seizure drug discovery
- (2019) Simona Lattanzi et al. Expert Opinion on Drug Discovery
- Edaravone for the treatment of amyotrophic lateral sclerosis
- (2019) Hiide Yoshino Expert Review of Neurotherapeutics
- Effects of Edaravone on Nitric Oxide, Hydroxyl Radicals and Neuronal Nitric Oxide Synthase During Cerebral Ischemia and Reperfusion in Mice
- (2019) Hitoshi Kawasaki et al. Journal of Stroke & Cerebrovascular Diseases
- Edaravone attenuates neuronal apoptosis in hypoxic-ischemic brain damage rat model via suppression of TRAIL signaling pathway
- (2018) Chunyi Li et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Neonatal hypoxic–ischemic encephalopathy: emerging therapeutic strategies based on pathophysiologic phases of the injury
- (2018) Qiuli Wang et al. Journal of Maternal-Fetal & Neonatal Medicine
- Metformin: An Old Drug with New Applications
- (2018) Joseph Zhou et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Metformin: a review of its potential indications
- (2017) Yi-Wei Wang et al. Drug Design Development and Therapy
- Regulation of cell proliferation by hypoxia-inducible factors
- (2015) Maimon E. Hubbi et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Neuroprotective Strategies after Neonatal Hypoxic Ischemic Encephalopathy
- (2015) Brandon Dixon et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Protective effect of Edaravone against hypoxia-induced cytotoxicity in osteoblasts MC3T3-E1 cells
- (2015) Bo Cao et al. IUBMB LIFE
- Neuroglobin Overexpression Inhibits AMPK Signaling and Promotes Cell Anabolism
- (2015) Bin Cai et al. MOLECULAR NEUROBIOLOGY
- Anti-inflammatory effects of Edaravone and Scutellarin in activated microglia in experimentally induced ischemia injury in rats and in BV-2 microglia
- (2014) Yun Yuan et al. BMC NEUROSCIENCE
- Chronic metformin treatment improves post-stroke angiogenesis and recovery after experimental stroke
- (2014) Venugopal R. Venna et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Curcumin abates hypoxia-induced oxidative stress based-ER stress-mediated cell death in mouse hippocampal cells (HT22) by controlling Prdx6 and NF-κB regulation
- (2013) Bhavana Chhunchha et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Pharmacologic Neuroprotective Strategies in Neonatal Brain Injury
- (2013) Sandra E. Juul et al. CLINICS IN PERINATOLOGY
- Edaravone Protects HT22 Neurons from H2O2-induced Apoptosis by Inhibiting the MAPK Signaling Pathway
- (2012) Zhong-Yan Zhao et al. CNS Neuroscience & Therapeutics
- Free-Radical Scavenger Edaravone Treatment Confers Neuroprotection Against Traumatic Brain Injury in Rats
- (2011) Guo-Hua Wang et al. JOURNAL OF NEUROTRAUMA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now